Пређи на садржај

Финансијска исплативост алтернатива трансфузији крви

Кардиоторакална и васкуларна хирургија

The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. (отвара нови прозор)

Ad N, Holmes SD, Patel J, Shuman DJ, Massimiano PS, Choi E, Fitzgerald D, Halpin L, Fornaresio LM.

Извор‎: J Thorac Cardiovasc Surg 2017;153(3):597-605.e1.

Индекс‎: PubMed 27938898

DOI‎: 10.1016/j.jtcvs.2016.10.083

https://www.ncbi.nlm.nih.gov/pubmed/27938898 (отвара нови прозор)

Costs of bleeds relating to acute coronary syndrome therapies. (отвара нови прозор)

Bufe A, Emile F, Drogoul L, Guindo Soldevila J, Giuseppe DP, Maddalena L, Janzon M, Brown RE.

Извор‎: J Med Econ 2010;13(2):236-40.

Индекс‎: PubMed 20465368

DOI‎: 10.3111/13696998.2010.488882

https://www.ncbi.nlm.nih.gov/pubmed/20465368 (отвара нови прозор)

Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay. (отвара нови прозор)

Cahill CM, Alhasson B, Blumberg N, Melvin A, Knight P, Gloff M, Robinson R, Akwaa F, Refaai MA.

Извор‎: Transfusion 2021;61(9):2629-36.

Индекс‎: PubMed 34268778

DOI‎: 10.1111/trf.16564

https://www.ncbi.nlm.nih.gov/pubmed/34268778 (отвара нови прозор)

Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. (отвара нови прозор)

Chapman AJ, Blount AL, Davis AT, Hooker RL.

Извор‎: Eur J Cardiothorac Surg 2011;40(6):1314-8.

Индекс‎: PubMed 21601468

DOI‎: 10.1016/j.ejcts.2011.03.048

https://www.ncbi.nlm.nih.gov/pubmed/21601468 (отвара нови прозор)

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (отвара нови прозор)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Извор‎: Transfusion 2008;48(2):237-50.

Индекс‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (отвара нови прозор)

Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery. (отвара нови прозор)

Fung MK, Moore K, Ridenour M, Mook W, Triulzi DJ.

Извор‎: Transfusion 2006;46(3):386-91.

Индекс‎: PubMed 16533280

DOI‎: 10.1111/j.1537-2995.2006.00733.x

https://www.ncbi.nlm.nih.gov/pubmed/16533280 (отвара нови прозор)

Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven®): a propensity score analysis. (отвара нови прозор)

Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF.

Извор‎: Eur J Cardiothorac Surg 2008;33(1):64-71.

Индекс‎: PubMed 17996457

DOI‎: 10.1016/j.ejcts.2007.10.004

https://www.ncbi.nlm.nih.gov/pubmed/17996457 (отвара нови прозор)

How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost? (отвара нови прозор)

Guinn NR, Guercio JR, Hopkins TJ, Grimsley A, Kurian DJ, Jimenez MI, Bolognesi MP, Schroeder R, Aronson S; Duke Perioperative Enhancement Team (POET).

Извор‎: Transfusion 2016;56(2):297-303.

Индекс‎: PubMed 26592207

DOI‎: 10.1111/trf.13426

https://www.ncbi.nlm.nih.gov/pubmed/26592207 (отвара нови прозор)

Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. (отвара нови прозор)

Helm RE, Rosengart TK, Gomez M, Klemperer JD, DeBois WJ, Velasco F, Gold JP, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH.

Извор‎: Ann Thorac Surg 1998;65(1):125-36.

Индекс‎: PubMed 9456106

https://www.ncbi.nlm.nih.gov/pubmed/9456106 (отвара нови прозор)

Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial. (отвара нови прозор)

Hofmann B, Kaufmann C, Stiller M, Neitzel T, Wienke A, Silber RE, Treede H.

Извор‎: J Cardiothorac Surg 2018;13(1):50.

Индекс‎: PubMed 29784004

DOI‎: 10.1186/s13019-018-0739-0

https://www.ncbi.nlm.nih.gov/pubmed/29784004 (отвара нови прозор)

Economic evaluation of national patient blood management clinical guidelines in cardiac surgery. (отвара нови прозор)

Irving AH, Harris A, Petrie D, Higgins A, Smith JA, Tran L, Reid CM, McQuilten ZK.

Извор‎: Value Health 2022;25(3):419-26.

Индекс‎: PubMed 35227454

DOI‎: 10.1016/j.jval.2021.07.014

https://www.ncbi.nlm.nih.gov/pubmed/35227454 (отвара нови прозор)

Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. (отвара нови прозор)

LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, Rich JB, Kasirajan V, Fonner E Jr, Kron IL, Speir AM; Investigators for the Virginia Cardiac Surgery Quality Initiative.

Извор‎: J Thorac Cardiovasc Surg 2013;145(3):796-804.

Индекс‎: PubMed 23414992

DOI‎: 10.1016/j.jtcvs.2012.12.041

https://www.ncbi.nlm.nih.gov/pubmed/23414992 (отвара нови прозор)

Intraoperative cell salvage versus allogeneic transfusion during abdominal aortic surgery: clinical and financial outcomes. (отвара нови прозор)

Marković M, Davidović L, Savić N, Sindjelić R, Ille T, Dragas M.

Извор‎: Vascular 2009;17(2):83-92.

Индекс‎: PubMed 19426638

DOI‎: 10.2310/6670.2009.00009

https://www.ncbi.nlm.nih.gov/pubmed/19426638 (отвара нови прозор)

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. (отвара нови прозор)

Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD.

Извор‎: Circulation 2007;116(22):2544-52.

Индекс‎: PubMed 17998460

DOI‎: 10.1161/CIRCULATIONAHA.107.698977

https://www.ncbi.nlm.nih.gov/pubmed/17998460 (отвара нови прозор)

Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial. (отвара нови прозор)

Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, Caputo M, Angelini GD.

Извор‎: J Thorac Cardiovasc Surg 2005;130(1):20-8.

Индекс‎: PubMed 15999036

DOI‎: 10.1016/j.jtcvs.2004.12.006

https://www.ncbi.nlm.nih.gov/pubmed/15999036 (отвара нови прозор)

Bleeding after cardiac surgery is associated with an increase in the total cost of the hospital stay. (отвара нови прозор)

Newcomb AE, Dignan R, McElduff P, Pearse EJ, Bannon P.

Извор‎: Ann Thorac Surg 2020;109(4):1069-78.

Индекс‎: PubMed 31904370

DOI‎: 10.1016/j.athoracsur.2019.11.019

https://www.ncbi.nlm.nih.gov/pubmed/31904370 (отвара нови прозор)

Protocol guided bleeding management improves cardiac surgery patient outcomes. (отвара нови прозор)

Pearse BL, Smith I, Faulke D, Wall D, Fraser JF, Ryan EG, Drake L, Rapchuk IL, Tesar P, Ziegenfuss M, Fung YL.

Извор‎: Vox Sang 2015;109(3):267-79.

Индекс‎: PubMed 25930098

DOI‎: 10.1111/vox.12279

https://www.ncbi.nlm.nih.gov/pubmed/25930098 (отвара нови прозор)

Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. (отвара нови прозор)

Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB.

Извор‎: Am Heart J 2008;155(2):369-74.

Индекс‎: PubMed 18215610

DOI‎: 10.1016/j.ahj.2007.10.014

https://www.ncbi.nlm.nih.gov/pubmed/18215610 (отвара нови прозор)

Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters. (отвара нови прозор)

Redfors B, Watson BM, McAndrew T, Palisaitis E, Francese DP, Razavi M, Safirstein J, Mehran R, Kirtane AJ, Généreux P.

Извор‎: JAMA Cardiol 2017;2(7):798-802.

Индекс‎: PubMed 28315573

DOI‎: 10.1001/jamacardio.2017.0265

https://www.ncbi.nlm.nih.gov/pubmed/28315573 (отвара нови прозор)

Hospital economic impact from hemostatic matrix usage in cardiac surgery. (отвара нови прозор)

Tackett SM, Sugarman R, Kreuwel HT, Alvarez P, Nasso G.

Извор‎: J Med Econ 2014;17(9):670-6.

Индекс‎: PubMed 24927164

DOI‎: 10.3111/13696998.2014.928638

https://www.ncbi.nlm.nih.gov/pubmed/24927164 (отвара нови прозор)

A structured blood conservation programme reduces transfusions and costs in cardiac surgery. (отвара нови прозор)

Ternström L, Hyllner M, Backlund E, Schersten H, Jeppsson A.

Извор‎: Interact Cardiovasc Thorac Surg 2014;19(5):788-94.

Индекс‎: PubMed 25125140

DOI‎: 10.1093/icvts/ivu266

https://www.ncbi.nlm.nih.gov/pubmed/25125140 (отвара нови прозор)

Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. (отвара нови прозор)

Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA Jr, Ikonomidis JS.

Извор‎: J Thorac Cardiovasc Surg 2011;141(6):1469-77.e2.

Индекс‎: PubMed 21457998

DOI‎: 10.1016/j.jtcvs.2011.02.033

https://www.ncbi.nlm.nih.gov/pubmed/21457998 (отвара нови прозор)

Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy. (отвара нови прозор)

Yaffee DW, Smith DE 3rd, Ursomanno PA, Hill FT, Galloway AC, Deanda A, Grossi EA.

Извор‎: Ann Thorac Surg 2014;97(1):95-101.

Индекс‎: PubMed 24263014

DOI‎: 10.1016/j.athoracsur.2013.09.057

https://www.ncbi.nlm.nih.gov/pubmed/24263014 (отвара нови прозор)

Cost of bleeding in trauma and complex cardiac surgery. (отвара нови прозор)

Zbrozek A, Magee G.

Извор‎: Clin Ther 2015;37(9):1966-74.

Индекс‎: PubMed 26210074

DOI‎: 10.1016/j.clinthera.2015.06.007

https://www.ncbi.nlm.nih.gov/pubmed/26210074 (отвара нови прозор)